Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

February 26, 2015

VUMC’s Arteaga named a fellow of the AACR Academy

Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named a fellow of the AACR Academy.

By VUMC News and Communications
February 12, 2015

BlackHawk’s Cancer Center support reaches milestone

Country music group BlackHawk recently presented a check for $20,000 to Harold (Hal) Moses, M.D., Ingram Professor of Cancer Research and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), in support of cancer research.

By VUMC News and Communications
February 9, 2015

Gene profile predicts metastasis

A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, Vanderbilt researchers have found.

By Yan Su
February 5, 2015

Study to explore myeloma treatment’s impact on heart

Vanderbilt is embarking on an observational study to define and understand how a promising treatment for multiple myeloma affects the heart.

By Kathy Whitney
January 29, 2015

New therapy options enhance prostate cancer treatment

Vanderbilt-Ingram Cancer Center (VICC) patient William Ostman smiled while gazing into a camera lens and declared, “I am a prostate cancer survivor.”

By VUMC News and Communications
January 15, 2015

Cancer organizations call for regulation of e-cigarettes

Two leading cancer organizations are calling for regulation of e-cigarettes and other electronic nicotine delivery systems (ENDS).

By VUMC News and Communications
January 8, 2015

Study tracks combination therapy to treat melanoma

Melanoma is the most lethal form of skin cancer, with high mortality rates. While new drugs have been approved to treat the disease, patients nearly always develop resistance to the therapies and the cancer advances.
By VUMC News and Communications
January 8, 2015

Enzyme affects tumor metastasis

A protein that degrades the “matrix” between cells participates in the development of lung metastases from primary breast cancer in mouse models and may be a good target for breast cancer treatment.
By Daren Diiorio
December 18, 2014

Sounds of the season

Every holiday season, members of the Vanderbilt Community Chorus sing holiday-themed carols to Vanderbilt-Ingram Cancer Center patients, family members and visitors.
By VUMC News and Communications
December 11, 2014

Visit unites stem cell transplant patient, donor for first time

When Darlena Clark of Hendersonville, Tennessee, saw Jon Strong for the first time at Nashville International Airport she, “just grabbed him and hugged him and just held on.”
By VUMC News and Communications
November 20, 2014

Gene mutation linked to breast cancer therapy resistance

A group of Vanderbilt-led investigators has identified a new gene mutation that may explain why some breast cancer patients do not respond to anti-hormone therapy.
By VUMC News and Communications
November 20, 2014

Tindle to direct Tobacco Research and Treatment

November is well-known as Lung Cancer Awareness Month. It is also the month that highlights awareness of less publicized forms of cancer including pancreatic cancer and stomach cancer.
By VUMC News and Communications
November 11, 2014

Protein “pockets” help ID cancer genes

Vanderbilt investigators have used a computational biology approach to uncover new cancer drivers and biomarkers of anticancer drug response.
By Bill Snyder